| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.53 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |